Malignant growth is caused because of the unregulated expansion of cells. Grasping the distinctions between a disease cell and an ordinary cell; a typical tissue and a growth microenvironment is the way to fostering an effective designated drug conveyance framework for malignant growth chemotherapy. Antibodies and different ligands, well defined for various TAA are valuable for designated conveyance of anticancer medications with nanocarriers. Carbon nanomaterials and various boosts responsive polymers and lipids have made it plausible to convey an ideal portion of medications to malignant growth cells without appearance of foundational secondary effects. Multifunctional nanoparticles are the major of examination where the PPT, PDT and designated conveyance of chemotherapeutic specialists have been joined together to upgrade the remedial adequacy and inversion of MDR. Moreover, natural and inorganic materials with cytotoxicity have been changed over in to nanoparticles for disease treatment. These self-helpful nanomaterials have opened the new skyline of utilizations of materials science in malignant growth treatment.